{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:08:18Z","timestamp":1793898498089,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Astaxanthin (ATX) is a potent natural antioxidant that shows promise against hepatocellular carcinoma (HCC). We investigated the therapeutic potential of ATX and its impact on Wnt\/\u03b2-catenin pathway in a rat model, inducing HCC by nitrosodiethylamine (DEN) and carbon tetrachloride (CCl\n                    <jats:sub>4<\/jats:sub>\n                    ). Rats were divided into five groups; I: control, II: HCC, III: HCC rats received ATX (5 days\/week), IV: HCC rats received doxorubicin (DOX) weekly, V: HCC rats received combination therapy, for 4 weeks. Our results indicate that combination therapy significantly improved serum biomarkers, reducing alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alpha-fetoprotein (AFP) levels by 45%, 35%, 49%, respectively compared to untreated HCC rats. Histopathological examination revealed the absence of hepato-carcinogenic nodules in the DOX- and combination-treated groups. Furthermore, combination therapy downregulated Wnt\/\u03b2-catenin pathway components, decreasing frizzled-7 (FZD-7) by 56%, low-density lipoprotein receptor-related proteins 5\/6 (LRP5\/6) by 62%, \u03b2-catenin by 58%, and upregulating glycogen synthase kinase-3\u03b2 (GSK3\u03b2) by 41% compared to untreated HCC rats. Consequently, the expression of key proteins such as cyclin D1 was ameliorated by 46%. While DOX monotherapy upregulated multidrug resistance protein-1 (MDR1) by 65%, combination therapy mitigated this increase by 36%. These findings highlight that ATX has potential therapeutic benefits in HCC treatment in rats.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-45680-1","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T22:35:11Z","timestamp":1776724511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Astaxanthin suppresses hepatocellular carcinoma via targeting Wnt\/\u0392-catenin pathway: Experimental study on chemically induced HCC in rats"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-8833","authenticated-orcid":false,"given":"Mona A.","family":"Kortam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3408-0080","authenticated-orcid":false,"given":"Marwa Sh.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maher A.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0173-8125","authenticated-orcid":false,"given":"Noha A.","family":"El-Boghdady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"4","key":"45680_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4103\/1110-2098.167895","volume":"28","author":"NS Holah","year":"2015","unstructured":"Holah, N. S., El-Azab, D. S., Aiad, H. A. & Sweed, D. M. Hepatocellular carcinoma in Egypt: Epidemiological and histopathological properties. Menoufia Med. J. 28 (4), 718\u2013724. https:\/\/doi.org\/10.4103\/1110-2098.167895 (2015).","journal-title":"Menoufia Med. J."},{"issue":"1","key":"45680_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43046-020-0016-x","volume":"32","author":"WM Rashed","year":"2020","unstructured":"Rashed, W. M., Kandeil, M. A. M., Mahmoud, M. O. & Ezzat, S. Hepatocellular carcinoma (HCC) in Egypt: A comprehensive overview. J. Egypt. Natl. Cancer Inst. 32 (1), 1\u201311. https:\/\/doi.org\/10.1186\/s43046-020-0016-x (2020).","journal-title":"J. Egypt. Natl. Cancer Inst."},{"issue":"4","key":"45680_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4103\/0973-1482.139267","volume":"10","author":"S Rivankar","year":"2014","unstructured":"Rivankar, S. An overview of doxorubicin formulations in cancer therapy. J. Cancer Res. Ther. 10 (4), 853\u2013858. https:\/\/doi.org\/10.4103\/0973-1482.139267 (2014).","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"45680_CR4","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbcan.2013.12.002","volume":"1845","author":"F Yang","year":"2014","unstructured":"Yang, F., Teves, S. S., Kemp, C. J. & Henikoff, S. Doxorubicin, DNA torsion, and chromatin dynamics. Biochim. Biophys. Acta Rev. Cancer. 1845 (1), 84\u201389. https:\/\/doi.org\/10.1016\/j.bbcan.2013.12.002 (2014).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"45680_CR5","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.biopha.2018.08.104","volume":"107","author":"NM Abdel-Hamid","year":"2018","unstructured":"Abdel-Hamid, N. M., Abass, S. A., Mohamed, A. A. & Hamid, D. M. Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors. Biomed. Pharmacother. 107, 1246\u20131258. https:\/\/doi.org\/10.1016\/j.biopha.2018.08.104 (2018).","journal-title":"Biomed. Pharmacother"},{"issue":"4","key":"45680_CR6","first-page":"372","volume":"19","author":"K Sadek","year":"2020","unstructured":"Sadek, K., Abouzed, T., Nasr, S., Shoukry, M. & Licochalcone, B. Ameliorates liver cancer via targeting of apoptotic genes, DNA repair systems, and cell cycle control. Iran. J. Pharm. Res. 19 (4), 372\u2013386 (2020).","journal-title":"Iran. J. Pharm. Res."},{"issue":"11","key":"45680_CR7","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1139\/cjpp-2015-0596","volume":"94","author":"K Sadek","year":"2016","unstructured":"Sadek, K., Beltagy, D., Saleh, E. & Abouelkhair, R. Camel milk and bee honey regulate pro-fibrotic cytokine gene transcripts in carbon tetrachloride-induced liver cirrhosis. Can. J. Physiol. Pharmacol. 94 (11), 1141\u20131150 (2016).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"8","key":"45680_CR8","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.3390\/cancers13081830","volume":"3","author":"Y Krutsenko","year":"2021","unstructured":"Krutsenko, Y., Singhi, A. D. & Monga, S. P. \u03b2-Catenin activation in hepatocellular cancer: Implications in biology and therapy. Cancers 3 (8), 1830. https:\/\/doi.org\/10.3390\/cancers13081830 (2021).","journal-title":"Cancers"},{"key":"45680_CR9","doi-asserted-by":"publisher","first-page":"110851","DOI":"10.1016\/j.biopha.2020.110851","volume":"132","author":"S He","year":"2020","unstructured":"He, S. & Tang, S. WNT \u03b2-catenin signaling in the development of liver cancers. Biomed. Pharmacother. 132, 110851. https:\/\/doi.org\/10.1016\/j.biopha.2020.110851 (2020).","journal-title":"Biomed. Pharmacother"},{"issue":"1","key":"45680_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S1665-2681(19)30802-6","volume":"14","author":"I Suarez","year":"2015","unstructured":"Suarez, I. et al. Wnt\/\u03b2-catenin signaling pathway in hepatocellular carcinomas cases from Colombia. Ann. Hepatol. 14 (1), 64\u201374. https:\/\/doi.org\/10.1016\/S1665-2681(19)30802-6 (2015).","journal-title":"Ann. Hepatol."},{"issue":"1","key":"45680_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7324\/JABB.2021.9115","volume":"9","author":"J Medhi","year":"2021","unstructured":"Medhi, J., Kalita, M. C. & Astaxanthin An algae-based natural compound with a potential role in human health-promoting effect: An updated comprehensive review. J. Appl. Biol. Biotechnol. 9 (1), 114\u2013123. https:\/\/doi.org\/10.7324\/JABB.2021.9115 (2021).","journal-title":"J. Appl. Biol. Biotechnol."},{"key":"45680_CR12","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.2147\/DDDT.S230749","volume":"14","author":"J Li","year":"2020","unstructured":"Li, J., Guo, C. & Wu, J. Astaxanthin in liver health and disease: A potential therapeutic agent. Drug Des. Dev. Ther. 14, 2275\u20132285. https:\/\/doi.org\/10.2147\/DDDT.S230749 (2020).","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"45680_CR13","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/md12010128","volume":"12","author":"RR Ambati","year":"2014","unstructured":"Ambati, R. R., Phang, S. M., Ravi, S., Aswathanarayana, R. G. & Astaxanthin Sources, extraction, stability, biological activities and its commercial applications - A review. Mar. Drugs. 12 (1), 128\u2013152. https:\/\/doi.org\/10.3390\/md12010128 (2014).","journal-title":"Mar. Drugs"},{"issue":"1","key":"45680_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3892\/ijmm.2020.4783","volume":"47","author":"CPM Pereira","year":"2021","unstructured":"Pereira, C. P. M., Souza, A. C. R., Vasconcelos, A. R. & Prado, P. S. Antioxidant and anti-inflammatory mechanisms of action of astaxanthin in cardiovascular diseases. Int. J. Mol. Med. 47 (1), 37\u201348. https:\/\/doi.org\/10.3892\/ijmm.2020.4783 (2021).","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"45680_CR15","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.3390\/md13074310","volume":"13","author":"L Zhang","year":"2015","unstructured":"Zhang, L. & Wang, H. Multiple mechanisms of anti-cancer effects exerted by astaxanthin. Mar. Drugs. 13 (7), 4310\u20134330. https:\/\/doi.org\/10.3390\/md13074310 (2015).","journal-title":"Mar. Drugs"},{"key":"45680_CR16","doi-asserted-by":"publisher","first-page":"104689","DOI":"10.1016\/j.phrs.2020.104689","volume":"155","author":"I Faraone","year":"2020","unstructured":"Faraone, I. et al. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review. Pharmacol. Res. 155, 104689. https:\/\/doi.org\/10.1016\/j.phrs.2020.104689 (2020).","journal-title":"Pharmacol. Res."},{"issue":"10","key":"45680_CR17","doi-asserted-by":"publisher","first-page":"6064","DOI":"10.3390\/md13106064","volume":"13","author":"J Li","year":"2015","unstructured":"Li, J. et al. Astaxanthin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells via inhibition of of Nf-\u039ab P65 and Wnt\/\u0392-catenin in vitro. Mar. Drugs. 13 (10), 6064\u20136081. https:\/\/doi.org\/10.3390\/md13106064 (2015).","journal-title":"Mar. Drugs"},{"issue":"1","key":"45680_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5487\/TR.2014.30.1.001","volume":"30","author":"J Jung","year":"2014","unstructured":"Jung, J. Human tumor xenograft models for preclinical assessment of anticancer drug development. Toxicol. Res. 30 (1), 1\u20135. https:\/\/doi.org\/10.5487\/TR.2014.30.1.001 (2014).","journal-title":"Toxicol. Res."},{"issue":"7","key":"45680_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1002\/hep4.1365","volume":"3","author":"T Blumer","year":"2019","unstructured":"Blumer, T. et al. Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors. Hepatol. Commun. 3 (7), 971\u2013986. https:\/\/doi.org\/10.1002\/hep4.1365 (2019).","journal-title":"Hepatol. Commun."},{"key":"45680_CR20","doi-asserted-by":"publisher","unstructured":"Uehara, T., Pogribny, I. P. & Rusyn, I. The DEN and CCl4-induced mouse model of fibrosis and inflammation\u2010associated hepatocellular carcinoma. Curr. Protoc. https:\/\/doi.org\/10.1002\/cpz1.211 (2021).","DOI":"10.1002\/cpz1.211"},{"issue":"1","key":"45680_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbagen.2013.08.020","volume":"1840","author":"D Sengupta","year":"2014","unstructured":"Sengupta, D., Chowdhury, K. D., Sarkar, A., Paul, S. & Sadhukhan, G. C. Berberine and S allyl cysteine mediated amelioration of DEN\u2009+\u2009CCl4 induced hepatocarcinoma. Biochim. Biophys. Acta Gen. Subj. 1840 (1), 219\u2013244. https:\/\/doi.org\/10.1016\/j.bbagen.2013.08.020 (2014).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"6","key":"45680_CR22","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.21608\/ejhm.2019.43804","volume":"76","author":"EL Sayed","year":"2019","unstructured":"Sayed, E. L., Morsy, H. E., Abo, L. E., Emara, T. M. & Galhom, R. A. Effect of carbon tetrachloride (CCL4) on liver in adult albino rats: Histological study. Egypt. J. Hosp. Med. 76 (6), 4254\u20134261. https:\/\/doi.org\/10.21608\/ejhm.2019.43804 (2019).","journal-title":"Egypt. J. Hosp. Med."},{"issue":"2","key":"45680_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molonc.2013.01.005","volume":"7","author":"L Bakiri","year":"2013","unstructured":"Bakiri, L. & Wagner, E. F. Mouse models for liver cancer. Mol. Oncol. 7 (2), 206\u2013223. https:\/\/doi.org\/10.1016\/j.molonc.2013.01.005 (2013).","journal-title":"Mol. Oncol."},{"issue":"3","key":"45680_CR24","doi-asserted-by":"publisher","first-page":"101042831769592","DOI":"10.1177\/1010428317695923","volume":"39","author":"NP Santos","year":"2017","unstructured":"Santos, N. P., Cola\u00e7o, A. A. & Oliveira, P. A. Animal models as a tool in hepatocellular carcinoma research: A Review. Tumor Biol. 39 (3), 1010428317695923. https:\/\/doi.org\/10.1177\/1010428317695923 (2017).","journal-title":"Tumor Biol."},{"issue":"3","key":"45680_CR25","doi-asserted-by":"publisher","first-page":"E201","DOI":"10.1111\/hepr.12550","volume":"46","author":"T Ohno","year":"2016","unstructured":"Ohno, T. et al. Preventive effects of astaxanthin on diethylnitrosamine-induced liver tumorigenesis in C57\/BL\/KsJ-db\/db obese mice. Hepatol. Res. 46 (3), E201\u2013E209. https:\/\/doi.org\/10.1111\/hepr.12550 (2016).","journal-title":"Hepatol. Res."},{"issue":"6","key":"45680_CR26","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.1007\/s13369-020-04478-7","volume":"45","author":"WS Alansari","year":"2020","unstructured":"Alansari, W. S. & Eskandrani, A. A. The anticarcinogenic effect of the apple polyphenol phloretin in an experimental rat model of hepatocellular carcinoma. Arab. J. Sci. Eng. 45 (6), 4589\u20134597. https:\/\/doi.org\/10.1007\/s13369-020-04478-7 (2020).","journal-title":"Arab. J. Sci. Eng."},{"key":"45680_CR27","doi-asserted-by":"publisher","first-page":"e13434","DOI":"10.1111\/asj.13434","volume":"91","author":"MM Zeweil","year":"2020","unstructured":"Zeweil, M. M. et al. Sidr honey abrogates the oxidative stress and downregulates the hyaluronic acid concentration and gene expression of TGF- \u03b2 1 and COL1a1 in rat model of thioacetamide-induced hepatic fibrosis. Anim. Sci. J. 91, e13434 (2020).","journal-title":"Anim. Sci. J."},{"issue":"12","key":"45680_CR28","doi-asserted-by":"publisher","first-page":"e13523","DOI":"10.1111\/jfbc.13523","volume":"44","author":"DS Metibemu","year":"2020","unstructured":"Metibemu, D. S. et al. Carotenoid isolates of Spondias mombin demonstrate anticancer effects in DMBA-induced breast cancer in Wistar rats through X-linked inhibitor of apoptosis protein (XIAP) antagonism and anti-inflammation. J. Food Biochem. 44 (12), e13523. https:\/\/doi.org\/10.1111\/jfbc.13523 (2020).","journal-title":"J. Food Biochem."},{"issue":"7","key":"45680_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/0748233711434959","volume":"29","author":"H Turkez","year":"2013","unstructured":"Turkez, H., Geyikoglu, F. & Yousef, M. I. Beneficial effect of astaxanthin on 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced liver injury in rats. Toxicol. Ind. Health. 29 (7), 591\u2013599. https:\/\/doi.org\/10.1177\/0748233711434959 (2013).","journal-title":"Toxicol. Ind. Health"},{"issue":"3","key":"45680_CR30","first-page":"560","volume":"25","author":"SM Jasim","year":"2021","unstructured":"Jasim, S. M. & Jwad, S. M. Astaxanthin extract potentiates the functional performance of hepatic and renal tissues and can prevent or alleviate hepatotoxicity and nephrotoxicity induced by acetaminophen. Ann. Rom Soc. Cell. Biol. 25 (3), 560\u2013568 (2021).","journal-title":"Ann. Rom Soc. Cell. Biol."},{"key":"45680_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.lfs.2017.11.036","volume":"192","author":"MA Lebda","year":"2018","unstructured":"Lebda, M. A., Sadek, K. M., Abouzed, T. K., Tohamy, H. G. & El-Sayed, Y. S. Melatonin mitigates thioacetamide-induced hepatic fi brosis via antioxidant activity and modulation of proin fl ammatory cytokines and fi brogenic genes. Life Sci. 192, 136\u2013143 (2018).","journal-title":"Life Sci."},{"issue":"5","key":"45680_CR32","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.3892\/ol.2018.8292","volume":"15","author":"Y Xue","year":"2018","unstructured":"Xue, Y. et al. Downregulation of Frizzled-7 induces the apoptosis of hepatocellular carcinoma cells through inhibition of NF-\u03baB. Oncol. Lett. 15 (5), 7693\u20137701. https:\/\/doi.org\/10.3892\/ol.2018.8292 (2018).","journal-title":"Oncol. Lett."},{"key":"45680_CR33","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2147\/JHC.S336858","volume":"8","author":"M Deldar Abad Paskeh","year":"2021","unstructured":"Deldar Abad Paskeh, M., Mirzaei, S., Ashrafizadeh, M., Zarrabi, A. & Sethi, G. Wnt \/ \u03b2 -Catenin signaling as a driver of hepatocellular carcinoma progression: An emphasis on molecular pathways. J. Hepatocell Carcinoma. 8, 1415\u20131444. https:\/\/doi.org\/10.2147\/JHC.S336858 (2021).","journal-title":"J. Hepatocell Carcinoma"},{"issue":"4","key":"45680_CR34","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3892\/br.2025.1944","volume":"22","author":"C Copat","year":"2025","unstructured":"Copat, C. et al. Astaxanthin in cancer therapy and prevention. Biomed. Rep. 22 (4), 66. https:\/\/doi.org\/10.3892\/br.2025.1944 (2025).","journal-title":"Biomed. Rep."},{"issue":"5","key":"45680_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0036565","volume":"7","author":"EKK Tung","year":"2012","unstructured":"Tung, E. K. K., Wong, B. Y. C., Yau, T. O. & Ng, I. O. L. Upregulation of the Wnt co-receptor LRP6 promotes hepatocarcinogenesis and enhances cell invasion. PLoS One. 7 (5), 1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0036565 (2012).","journal-title":"PLoS One"},{"issue":"3","key":"45680_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3727\/105221618X15205148413587","volume":"18","author":"M Preziosi","year":"2018","unstructured":"Preziosi, M., Poddar, M., Singh, S. & Monga, S. P. Hepatocyte wnts are dispensable during diethylnitrosamine and carbon tetrachloride-induced injury and hepatocellular cancer. Gene Expr. 18 (3), 209\u2013219. https:\/\/doi.org\/10.3727\/105221618X15205148413587 (2018).","journal-title":"Gene Expr"},{"issue":"10","key":"45680_CR37","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.18632\/oncotarget.2037","volume":"5","author":"JA Mccubrey","year":"2014","unstructured":"Mccubrey, J. A. et al. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 5 (10), 2881\u20132911. https:\/\/doi.org\/10.18632\/oncotarget.2037 (2014).","journal-title":"Oncotarget"},{"issue":"2","key":"45680_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0304-3835(03)00421-X","volume":"199","author":"KC Ban","year":"2003","unstructured":"Ban, K. C., Singh, H., Krishnan, R. & Seow, H. F. GSK-3\u03b2 phosphorylation and alteration of \u03b2-catenin in 8390hepatocellular carcinoma. Cancer Lett. 199 (2), 201\u2013208. https:\/\/doi.org\/10.1016\/S0304-3835(03)00421-X (2003).","journal-title":"Cancer Lett."},{"issue":"10","key":"45680_CR39","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/iub.2104","volume":"71","author":"J Kowshik","year":"2019","unstructured":"Kowshik, J. et al. Astaxanthin inhibits hallmarks of cancer by targeting the PI3K\/NF-\u03ba\u0392\/STAT3 signalling axis in oral squamous cell carcinoma models. IUBMB Life. 71 (10), 1595\u20131610. https:\/\/doi.org\/10.1002\/iub.2104 (2019).","journal-title":"IUBMB Life"},{"issue":"7","key":"45680_CR40","doi-asserted-by":"publisher","first-page":"103308","DOI":"10.1016\/j.sjbs.2022.103308","volume":"29","author":"DO Saleh","year":"2022","unstructured":"Saleh, D. O., Mahmoud, S. S., Hassan, A. & Sanad, E. F. Doxorubicin-induced hepatic toxicity in rats: Mechanistic protective role of Omega-3 fatty acids through Nrf2\/HO-1 activation and PI3K\/Akt\/GSK-3\u03b2 axis modulation. Saudi J. Biol. Sci. 29 (7), 103308. https:\/\/doi.org\/10.1016\/j.sjbs.2022.103308 (2022).","journal-title":"Saudi J. Biol. Sci."},{"issue":"1","key":"45680_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald, B. T., Tamai, K. & He, X. Wnt\/\u03b2-catenin signaling: Components, mechanisms, and diseases. Dev. Cell. 17 (1), 9\u201326. https:\/\/doi.org\/10.1016\/j.devcel.2009.06.016 (2009).","journal-title":"Dev. Cell."},{"key":"45680_CR42","doi-asserted-by":"publisher","first-page":"111714","DOI":"10.1016\/j.fct.2020.111714","volume":"145","author":"SN Zarneshan","year":"2020","unstructured":"Zarneshan, S. N., Fakhri, S., Farzaei, M. H., Khan, H. & Saso, L. Astaxanthin targets PI3K\/Akt signaling pathway toward potential therapeutic applications. Food Chem. Toxicol. 145, 111714. https:\/\/doi.org\/10.1016\/j.fct.2020.111714 (2020).","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"45680_CR43","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/nrc3090","volume":"11","author":"EA Musgrove","year":"2011","unstructured":"Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A. & Sutherland, R. L. Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer. 11 (8), 558\u2013572. https:\/\/doi.org\/10.1038\/nrc3090 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"45680_CR44","doi-asserted-by":"publisher","first-page":"120242","DOI":"10.1016\/j.lfs.2021.120242","volume":"289","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Chemotherapeutic drugs induce oxidative stress associated with DNA repair and metabolism modulation. Life Sci. 289, 120242. https:\/\/doi.org\/10.1016\/j.lfs.2021.120242 (2022).","journal-title":"Life Sci."},{"issue":"3","key":"45680_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/mc.2940140304","volume":"14","author":"T Deguchi","year":"1995","unstructured":"Deguchi, T. & Pitot, H. C. Expression of c-myc in altered hepatic foci induced in rats by various single doses of diethylnitrosamine and promotion by 0.05% phenobarbital. Mol. Carcinog. 14 (3), 152\u2013159. https:\/\/doi.org\/10.1002\/mc.2940140304 (1995).","journal-title":"Mol. Carcinog."},{"issue":"5382","key":"45680_CR46","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","volume":"281","author":"TC He","year":"1998","unstructured":"He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281 (5382), 1509\u20131512. https:\/\/doi.org\/10.1126\/science.281.5382.1509 (1998).","journal-title":"Science"},{"issue":"20","key":"45680_CR47","doi-asserted-by":"publisher","first-page":"5903","DOI":"10.1158\/0008-5472.CAN-14-0527","volume":"74","author":"H Akita","year":"2014","unstructured":"Akita, H. et al. MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism. Cancer Res. 74 (20), 5903\u20135913. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0527 (2014).","journal-title":"Cancer Res."},{"issue":"1","key":"45680_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1089\/ars.2008.2095","volume":"11","author":"MT Kuo","year":"2009","unstructured":"Kuo, M. T. Redox regulation of multidrug resistance in cancer chemotherapy: Molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal. 11 (1), 99\u2013133. https:\/\/doi.org\/10.1089\/ars.2008.2095 (2009).","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"45680_CR49","doi-asserted-by":"publisher","first-page":"407","DOI":"10.14744\/cpr.2025.27738","volume":"47","author":"N Kalu\u00e7","year":"2025","unstructured":"Kalu\u00e7, N. & Thomas, P. B. Astaxanthin provides cytoprotection in response to oxidative stress in an autophagy-dependent manner. J. Clin. Pract. Res. 47 (4), 407\u2013414. https:\/\/doi.org\/10.14744\/cpr.2025.27738 (2025).","journal-title":"J. Clin. Pract. Res."},{"issue":"3","key":"45680_CR50","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman, G. et al. Drug resistance in cancer: An overview. Cancers 6 (3), 1769\u20131792. https:\/\/doi.org\/10.3390\/cancers6031769 (2014).","journal-title":"Cancers"},{"issue":"1","key":"45680_CR51","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman, M. M., Fojo, T. & Bates, S. E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer. 2 (1), 48\u201358. https:\/\/doi.org\/10.1038\/nrc706 (2002).","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"45680_CR52","doi-asserted-by":"publisher","first-page":"4659","DOI":"10.1039\/C9FO02429H","volume":"11","author":"H Ma","year":"2020","unstructured":"Ma, H. et al. Astaxanthin from: Haematococcus pluvialis ameliorates the chemotherapeutic drug (doxorubicin) induced liver injury through the Keap1\/Nrf2\/HO-1 pathway in mice. Food Funct. 11 (5), 4659\u20134671. https:\/\/doi.org\/10.1039\/C9FO02429H (2020).","journal-title":"Food Funct."},{"key":"45680_CR53","doi-asserted-by":"publisher","unstructured":"Islam, M. A. et al. Astaxanthin Ameliorates Hepatic Damage and Oxidative Stress in Carbon Tetrachloride\u2013administered Rats. Pharmacogn Res. https:\/\/doi.org\/10.4103\/pr.pr_26_17 (2017).","DOI":"10.4103\/pr.pr_26_17"},{"issue":"1\u20132","key":"45680_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0009-3084(01)00136-0","volume":"113","author":"A Shibata","year":"2001","unstructured":"Shibata, A., Kiba, Y., Akati, N., Fukuzawa, K. & Terada, H. Molecular characteristics of astaxanthin and \u03b2-carotene in the phospholipid monolayer and their distributions in the phospholipid bilayer. Chem. Phys. Lipids. 113 (1\u20132), 11\u201322. https:\/\/doi.org\/10.1016\/S0009-3084(01)00136-0 (2001).","journal-title":"Chem. Phys. Lipids"},{"key":"45680_CR55","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3389\/fphys.2019.01449","volume":"10","author":"Y Wei","year":"2019","unstructured":"Wei, Y. et al. Remarkable protective effects of Nrf2-mediated antioxidant enzymes and tissue specificity in different skeletal muscles of daurian ground squirrels over the torpor-arousal cycle. Front. Physiol. 10, 1449. https:\/\/doi.org\/10.3389\/fphys.2019.01449 (2019).","journal-title":"Front. Physiol."},{"issue":"3","key":"45680_CR56","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/0394632015621319","volume":"29","author":"I Bing\u00fcl","year":"2016","unstructured":"Bing\u00fcl, I. et al. Blueberry treatment attenuated cirrhotic and preneoplastic lesions and oxidative stress in the liver of diethylnitrosamine-treated rats. Int. J. Immunopathol. Pharmacol. 29 (3), 426\u2013437. https:\/\/doi.org\/10.1177\/0394632015621319 (2016).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"45680_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.5114\/wo.2021.110048","volume":"25","author":"G Atwa","year":"2021","unstructured":"Atwa, G., Omran, G., Elbaky, A. A. & Okda, T. The antitumour effect of galangin and luteolin with doxorubicin on chemically induced hepatocellular carcinoma in rats. Contemp. Oncol. \/Wsp\u00f3\u0142czesna Onkol. 25 (3), 174\u2013184. https:\/\/doi.org\/10.5114\/wo.2021.110048 (2021).","journal-title":"Contemp. Oncol. \/Wsp\u00f3\u0142czesna Onkol"},{"issue":"15","key":"45680_CR58","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.clinbiochem.2007.06.012","volume":"40","author":"KT Lee","year":"2007","unstructured":"Lee, K. T. et al. Glutathione status in the blood and tissues of patients with virus-originated hepatocellular carcinoma. Clin. Biochem. 40 (15), 1157\u20131162. https:\/\/doi.org\/10.1016\/j.clinbiochem.2007.06.012 (2007).","journal-title":"Clin. Biochem."},{"issue":"5","key":"45680_CR59","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1258\/acb.2009.009029","volume":"46","author":"SM Tsai","year":"2009","unstructured":"Tsai, S. M. et al. Evaluation of redox statuses in patients with hepatitis B virus-associated hepatocellular carcinoma. Ann. Clin. Biochem. 46 (5), 394\u2013400. https:\/\/doi.org\/10.1258\/acb.2009.009029 (2009).","journal-title":"Ann. Clin. Biochem."},{"issue":"6","key":"45680_CR60","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.3390\/cancers12061668","volume":"12","author":"M Mossenta","year":"2020","unstructured":"Mossenta, M., Busato, D., Dal Bo, M. & Toffoli, G. Glucose metabolism and oxidative stress in hepatocellular carcinoma: Role and possible implications in novel therapeutic strategies. Cancers 12 (6), 1668. https:\/\/doi.org\/10.3390\/cancers12061668 (2020).","journal-title":"Cancers"},{"issue":"5","key":"45680_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00394-007-0665-8","volume":"46","author":"CC Lin","year":"2007","unstructured":"Lin, C. C. & Yin, M. C. B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer. Eur. J. Nutr. 46 (5), 293\u2013299. https:\/\/doi.org\/10.1007\/s00394-007-0665-8 (2007).","journal-title":"Eur. J. Nutr."},{"issue":"9\u201310","key":"45680_CR62","doi-asserted-by":"publisher","first-page":"969","DOI":"10.7754\/clin.lab.2012.120712","volume":"59","author":"RS Yahya","year":"2013","unstructured":"Yahya, R. S., Ghanem, O. H., Foyouh, A. A., Atwa, M. A. & Enany, S. A. Role of interleukin-8 and oxidative stress in patients with hepatocellular carcinoma. Clin. Lab. 59 (9\u201310), 969\u2013976. https:\/\/doi.org\/10.7754\/clin.lab.2012.120712 (2013).","journal-title":"Clin. Lab."},{"issue":"5","key":"45680_CR63","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/ncb1405","volume":"8","author":"Y Funato","year":"2006","unstructured":"Funato, Y., Michiue, T., Asashima, M. & Miki, H. The thioredoxin-related redox-regulating protein nucleoredoxin inhibits Wnt \u2013 \u03b2 -catenin signalling through Dishevelled. Nat. Cell. Biol. 8 (5), 501\u2013508. https:\/\/doi.org\/10.1038\/ncb1405 (2006).","journal-title":"Nat. Cell. Biol."},{"issue":"11","key":"45680_CR64","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman, P. et al. Guidelines for the welfare and use of animals in cancer research. Br. J. Cancer. 102 (11), 1555\u20131577. https:\/\/doi.org\/10.1038\/sj.bjc.6605642 (2010).","journal-title":"Br. J. Cancer"},{"issue":"9","key":"45680_CR65","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1177\/0271678X20943823","volume":"40","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. JCBFM 40 (9), 1769\u20131777. https:\/\/doi.org\/10.1177\/0271678X20943823 (2020).","journal-title":"JCBFM"},{"issue":"2","key":"45680_CR66","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s13277-015-3920-2","volume":"37","author":"TK Motawi","year":"2016","unstructured":"Motawi, T. K., El-Boghdady, N. A., El-Sayed, A. M. & Helmy, H. S. Comparative study of the effects of PEGylated interferon-\u03b12a versus 5-fluorouracil on cancer stem cells in a rat model of hepatocellular carcinoma. Tumor Biol. 37 (2), 1617\u20131625. https:\/\/doi.org\/10.1007\/s13277-015-3920-2 (2016).","journal-title":"Tumor Biol."},{"key":"45680_CR67","doi-asserted-by":"publisher","unstructured":"Golla, K., Cherukuvada, B., Ahmed, F., Kondapi, A. K. & Efficacy Safety and Anticancer Activity of Protein Nanoparticle-Based Delivery of Doxorubicin through Intravenous Administration in Rats. PloS One. https:\/\/doi.org\/10.1371\/journal.pone.0051960 (2012). e51960.","DOI":"10.1371\/journal.pone.0051960"},{"issue":"1","key":"45680_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mrgentox.2009.12.014","volume":"696","author":"DN Tripathi","year":"2010","unstructured":"Tripathi, D. N. & Jena, G. B. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidativestress, DNA damage and early hepatocarcinogenesis in rat: Role of Nrf2, p53, p38 and phase-II enzymes. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 696 (1), 69\u201380. https:\/\/doi.org\/10.1016\/j.mrgentox.2009.12.014 (2010).","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"issue":"1","key":"45680_CR69","doi-asserted-by":"publisher","first-page":"12686","DOI":"10.1038\/s41598-023-39177-4","volume":"13","author":"NEA El-Naggar","year":"2023","unstructured":"El-Naggar, N. E. A. et al. Artificial neural network approach for prediction of AuNPs biosynthesis by Streptomyces flavolimosus, characterization, antitumor potency in-vitro and in-vivo against Ehrlich ascites carcinoma. Sci. Rep. 13 (1), 12686. https:\/\/doi.org\/10.1038\/s41598-023-39177-4 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"45680_CR70","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0003-2697(80)90139-6","volume":"106","author":"OW Griffith","year":"1980","unstructured":"Griffith, O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106 (1), 207\u2013212. https:\/\/doi.org\/10.1016\/0003-2697(80)90139-6 (1980).","journal-title":"Anal. Biochem."},{"key":"45680_CR71","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0076-6879(90)86135-I","volume":"186","author":"HH Draper","year":"1990","unstructured":"Draper, H. H. & Hadley, M. Malondialdehyde determination as index of lipid Peroxidation. Methods Enzymol. 186, 421\u2013431. https:\/\/doi.org\/10.1016\/0076-6879(90)86135-I (1990).","journal-title":"Methods Enzymol."},{"issue":"1","key":"45680_CR72","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowery","year":"1951","unstructured":"Lowery, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1), 265\u2013275. https:\/\/doi.org\/10.1016\/S0021-9258(19)52451-6 (1951).","journal-title":"J. Biol. Chem."},{"key":"45680_CR73","unstructured":"Harlow, E. & Lane, D. Using antibodies: A laboratory manual (CSHL, 1999)."},{"issue":"1","key":"45680_CR74","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3892\/etm.2019.8173","volume":"19","author":"M Gowayed","year":"2020","unstructured":"Gowayed, M., Mahmoud, S., El\u2013Sayed, Y., Abu Samra, N. & Kamel, M. Enhanced mitochondrial biogenesis is associated with the ameliorative action of creatine supplementation in rat soleus and cardiac muscles. Exp. Ther. Med. 19 (1), 384\u2013392. https:\/\/doi.org\/10.3892\/etm.2019.8173 (2020).","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"45680_CR75","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1177\/0300985813485099","volume":"50","author":"KN Gibson-corley","year":"2013","unstructured":"Gibson-corley, K. N., Olivier, A. K. & Meyerholz, D. K. Principles for valid histopathologic scoring in research. Vet. Pathol. 50 (6), 1007\u20131015. https:\/\/doi.org\/10.1177\/0300985813485099 (2013).","journal-title":"Vet. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45680-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:26:49Z","timestamp":1781648809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45680-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45680"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45680-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12928"}}